Home › Upcoming votes › Jaguar Health, Inc.
This meeting took place on November 6, 2026. Official results not yet filed. Companies report them on Form 8-K, usually within four business days of the meeting; they will appear here once they have been read.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in Jaguar Health, Inc.’s proxy statement, with the board’s recommendation on each item. The company has filed 1 set of additional materials since; they can add to or change what is below, so check them before relying on it.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | APPROVAL OF THE ISSUANCE OF SHARES OF COMMON STOCK UPON EXCHANGE OF SERIES Q PREFERRED STOCK AND CVP DEBT | Board | For | — |
| 2 | APPROVAL OF THE REPRICING OF THE INVESTOR WARRANTS SO THAT EACH INVESTOR WARRANT HAS A NEW EXERCISE PRICE EQUAL TO $1.00 PER SHARE | Board | For | — |
| 3 | APPROVAL OF AN AMENDMENT OF THE 2014 STOCK INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR ISSUANCE UNDER THE 2014 STOCK INCENTIVE PLAN | Board | For | — |
| 4 | APPROVAL OF THE THIRTEENTH AMENDMENT TO OUR THIRD AMENDED AND | Board | For | — |
| 5 | APPROVAL OF AN AMENDMENT TO THE ELOC AGREEMENT TO REDUCE THE FLOOR PRICE FROM $16.50 PER SHARE TO $1.10 PER SHARE | Board | For | — |
| 6 | APPROVAL TO ADJOURN THE SPECIAL MEETING IF NECESSARY TO SOLICIT ADDITIONAL PROXIES Adjournment |
Board | For | — |
From Jaguar Health, Inc.’s Form 8-K, filed December 8, 2025, for the meeting held December 8, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| 1. Proposal to approve, for purposes of Nasdaq Listing Rule 5635(d) ("Rule 5635(d)"), the issuance of shares of Common Stock issuable upon e | 93% | — |
| 2. Proposal to approve, for purposes of Nasdaq Rule 5635(d), the issuance of shares of Common Stock (the "New PIPE Shares") and a pre-funded | 97% | — |
| 3. Proposal to approve, one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies in the event that there | 97% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.